Comment on cannabis products before April 16

Veterinarians have until April 16 to provide comments to the U.S. Food and Drug Administration (FDA) on the use of cannabis-derived products in animals. 

The FDA is looking specifically for information from practicing veterinarians, focusing on cannabidiol products and other products derived from hemp. The agency hopes to better understand veterinarians’ experience related to the use of these products in patients, including areas such as these:

• General patterns of use (animal species, brands, formulations, doses, indications for use)
• Quality standards
• Benefits of use
• Potential drug interactions
• Adverse events and safety problems
• Toxicological concerns

Submit comments here

Find more information in this AVMA News article: FDA asks for veterinarians’ comments on cannabis.

Cannabis resources for your veterinary team

The AVMA’s webpage Cannabis Use and Pets provides resources that help veterinarians talk with clients about cannabis. These include the report “Cannabis in Veterinary Medicine,” which provides a firm base of knowledge around the laws, science, and research concerning cannabis and companion animals.